Zenox, you had better hope that RedHill's strategy is better than their maths.
The percentages quoted in their latest press release do not compute, unless you exclude deaths from the equation. If this is the case, why not state the number of deaths up front?
When implied deaths are included, the treatment arm is still superior to the control arm, but their exclusion seems to have left a sour taste with investors. RDHL closed DOWN 5.6% in the USA after the Phase 2 results were released.
Zenox, you had better hope that RedHill's strategy is better...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
